Detalhe da pesquisa
1.
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation.
J Am Acad Dermatol
; 90(6): 1170-1181, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331098
2.
Differences in health care resource utilization and costs for keratinocyte carcinoma among racioethnic groups: A population-based study.
J Am Acad Dermatol
; 86(2): 373-378, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34246700
3.
Comparison of guidelines for the use of Ustekinumab for psoriasis in the United States, Europe, and the United Kingdom: A critical appraisal and comprehensive review.
Dermatol Ther
; 34(4): e14974, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33991048
4.
Differences in Depression and Distress Between Acne Patients on Isotretinoin vs Oral Antibiotics.
J Drugs Dermatol
; 20(2): 172-177, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538565
5.
Topical Agents Currently in Phase II or Phase III Trials for Atopic Dermatitis.
J Drugs Dermatol
; 19(10): 956-959, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33026767
6.
Abrocitinib for atopic dermatitis.
Lancet
; 397(10270): 195-196, 2021 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33453778
7.
Ruxolitinib cream for the treatment of vitiligo.
Lancet
; 396(10264): 1735-1736, 2020 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33248492
8.
Reply to Letter to the Editor Regarding: "Applying to dermatology residency during the COVID-19 pandemic".
J Am Acad Dermatol
; 84(1): e31-e32, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010318
9.
Understanding the Potential Role of Abrocitinib in the Time of SARS-CoV-2.
J Drugs Dermatol
; 20(7): 806, 2021 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34232002
10.
Assessing the Risk of Apremilast Use for Psoriasis During the COVID-19 Pandemic.
J Drugs Dermatol
; 20(5): 582-583, 2021 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33938697
11.
Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic.
J Am Acad Dermatol
; 83(3): e251-e252, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32534081
12.
Applying to dermatology residency during the COVID-19 pandemic.
J Am Acad Dermatol
; 83(4): 1214-1215, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32652192
13.
Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic.
J Am Acad Dermatol
; 83(6): e433-e434, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735966
14.
Use of systemic therapies for psoriasis in the COVID-19 era.
J Dermatolog Treat
; 33(2): 622-625, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32459567
15.
Management of Psoriasis With Topicals: Applying the 2020 AAD-NPF Guidelines of Care to Clinical Practice.
Cutis
; 110(2 Suppl): 8-14, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36219602
16.
Review and analysis of biologic therapies currently in phase II and phase III clinical trials for atopic dermatitis.
J Dermatolog Treat
; 33(2): 626-636, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32507066
17.
Clinical management of psoriasis patients during the COVID-19 pandemic.
J Dermatolog Treat
; 33(2): 1166-1167, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32568009
18.
Who sees you matters: a population study examining topical corticosteroid prescribing patterns between primary care providers and dermatologists for atopic dermatitis.
J Dermatolog Treat
; 33(3): 1507-1510, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33043730
19.
Language proficiency and biologics access: a population study of psoriasis patients in the United States.
J Dermatolog Treat
; 33(3): 1413-1417, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32928008
20.
Comparison of Guidelines for the Use of Interleukin-17 Inhibitors for Psoriasis in the United States, Britain, and Europe: A Critical Appraisal and Comprehensive Review.
J Clin Aesthet Dermatol
; 14(6): 55-59, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34804357